Evidence map›Paper›PMID 39808318›Full record

ArticlePediatric cardiology2025

Formulation of Quality Improvement Methodology for Risk Mitigation in Congenital Cardiac Catheterization.

Mary J Yeh, Elsa Bjornlund, Kimberlee Gauvreau, Fatima Ali, Nadeem Aslam, Sarosh P Batlivala, Darren Berman, Martin L Bocks, Kristin Chenault, Thomas Doyle and 12 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Mary J YehDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0001-9496-3462
Elsa BjornlundDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.
Kimberlee GauvreauDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0002-2597-3226
Fatima AliSection of Pediatric Cardiology, Department of Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan.
Nadeem AslamSection of Pediatric Cardiology, Department of Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan.
Sarosh P BatlivalaThe Heart Institute, Cincinnati Children's Hospital and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.ORCID https://orcid.org/0000-0002-8795-9526
Darren BermanDepartment of Cardiology, Children's Hospital Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0009-0005-6766-181X
Martin L BocksUH Rainbow Babies & Children's Hospital, Case Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID https://orcid.org/0000-0002-2778-5739
Kristin ChenaultThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.ORCID https://orcid.org/0000-0002-3196-6989
Thomas DoyleDivision of Pediatric Cardiology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, USA.
Todd GudauskyDivision of Cardiology, Children's Hospital of Wisconsin, Milwaukee, WI, USA.ORCID https://orcid.org/0000-0002-1599-9393
Michael HainstockDivision of Pediatric Cardiology, University of Virginia Children's Hospital, University of Virginia, Charlottesville, VA, USA.
Ralf HolzerUC Davis Children's Hospital, Sacramento, CA, USA.
Juan IblaDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, USA.
Michael L O'ByrneDivision of Cardiology, Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0001-6023-1634
Brian P QuinnDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.
Shabana ShahanavazThe Heart Institute, Cincinnati Children's Hospital and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.ORCID https://orcid.org/0000-0003-1620-9709
Ruchik SharmaDivision of Pediatric Cardiology, Department of Anesthesiology, University of Virginia Children's Hospital, University of Virginia, Charlottesville, VA, USA.
Sara M TruccoHeart Institute, UPMC Children's Hospital of Pittsburgh and Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Wendy WhitesideDivision of Pediatric Cardiology, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID https://orcid.org/0000-0003-2835-3847
Lisa BergersenDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0002-0115-1033
Aimee K ArmstrongThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA. aimee.armstrong@nationwidechildrens.org.ORCID https://orcid.org/0000-0002-4534-5075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The C3PO collaborative, with a history of successful quality improvement (QI) initiatives, leveraged registry participants to develop a multi-center QI initiative to reduce adverse events (AEs) in congenital cardiac catheterization. A 32-person, interdisciplinary working group analyzed audited data for all congenital cardiac catheterization cases from 2014-2017. The primary outcome was the occurrence of any high-severity (level 3/4/5) AE. Cases were organized from shortest to longest duration, and level 3/4/5 and 4/5 AE rates were summarized for each procedure duration decile. Observations from the root cause analysis were used to inform the creation of a key driver diagram and determine change strategies and implementation tools. To facilitate pre-procedure communication and risk assessment, an online risk calculator was developed using 2014-2019 data. Between 2014-2017, 14,717 cases were entered from 10 sites. Level 3/4/5 AEs occurred in 732 (5.0%) cases, while 4/5 AEs occurred in 224 (1.5%) cases. The key driver diagram defined three drivers: (1) Pre-Procedure Risk Assessment, (2) Possibly Preventable Events, and (3) Procedure Length Optimization. Actionable change strategies organized around five communication timepoints were developed in interdisciplinary discussions. Pre-case risk calculator outputs were available as a case summary print out and incorporated into a calendar for weekly schedule planning. Pre-intervention (2019) and preliminary intervention period data (2020-2021) are presented here. Through improved resource planning, the protocol equips catheterization teams to respond efficiently to AEs and possibly prevent escalation into dangerous events. This protocol provides reproducible interventions that can be adapted to local practice.

Indexed as

Cardiac CatheterizationHeart Defects, CongenitalQuality ImprovementFemaleHumansInfantInfant, NewbornMaleRegistriesRisk AssessmentAdverse eventsCongenital cardiac catheterizationQuality improvementRisk mitigation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.